Detalhe da pesquisa
1.
Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.
Int J Neuropsychopharmacol
; 23(7): 426-433, 2020 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270176
2.
Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform.
BMC Psychiatry
; 20(1): 384, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703173
3.
Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study.
BMC Psychiatry
; 20(1): 232, 2020 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404073
4.
All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population.
Ann Gen Psychiatry
; 18: 23, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31583010
5.
Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study.
BMC Psychiatry
; 18(1): 352, 2018 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373547
6.
Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.
Neurol Sci
; 37(2): 165-79, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26537494
7.
Robotic measurement of arm movements after stroke establishes biomarkers of motor recovery.
Stroke
; 45(1): 200-4, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335224
8.
Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials.
Pain Pract
; 14(4): 332-42, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23692321
9.
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study.
J Womens Health (Larchmt)
; 33(4): 480-490, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301149
10.
Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes.
Br J Clin Pharmacol
; 75(1): 146-61, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22534009
11.
The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials.
Alzheimers Dement
; 9(1 Suppl): S21-31, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23127469
12.
Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.
BMC Neurol
; 12: 46, 2012 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22731740
13.
Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.
Int J Methods Psychiatr Res
; 31(4): e1927, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35749277
14.
Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study.
Arch Suicide Res
; 25(3): 424-438, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-31774374
15.
Accurate prediction of clinical stroke scales and improved biomarkers of motor impairment from robotic measurements.
PLoS One
; 16(1): e0245874, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513170
16.
A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis.
Amyotroph Lateral Scler
; 11(6): 508-13, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20698808
17.
Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed.
J Affect Disord
; 271: 228-238, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32479321
18.
A register-based approach to identifying treatment-resistant depression-Comparison with clinical definitions.
PLoS One
; 15(7): e0236434, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730324
19.
Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study.
Addiction
; 115(4): 768-777, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31656053
20.
A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.
PLoS One
; 15(9): e0238843, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915863